Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | -0.05% | 129.65 | 0.0% | $2878.82m | |
| BNGO | BioNano Genomics, Inc. | 21.30% | 8.43 | 0.0% | $1523.88m | |
| GILD | Gilead Sciences, Inc. | 1.49% | 63.33 | 1.0% | $663.26m | |
| AMGN | Amgen, Inc. | 1.59% | 245.49 | 1.3% | $599.79m | |
| CRSP | CRISPR Therapeutics AG | -4.84% | 199.88 | 0.6% | $544.48m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.03% | 156.70 | 2.0% | $501.25m | |
| NVAX | Novavax, Inc. | -1.96% | 127.43 | 92.9% | $480.66m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.00% | 517.93 | 2.7% | $480.32m | |
| ILMN | Illumina, Inc. | 1.43% | 376.35 | 3.5% | $384.71m | |
| BIIB | Biogen, Inc. | -1.59% | 275.84 | 1.7% | $366.50m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -0.25% | 225.55 | 1.9% | $350.25m | |
| BNTX | BioNTech SE | -4.03% | 101.59 | 0.0% | $316.33m | |
| SRPT | Sarepta Therapeutics, Inc. | 0.47% | 90.32 | 13.8% | $296.56m | |
| OCGN | Ocugen, Inc. | 1.84% | 2.22 | 0.0% | $276.18m | |
| EDIT | Editas Medicine, Inc. | 0.29% | 76.14 | 7.9% | $256.07m |
Company Profile
Æterna Zentaris, Inc. operates as a specialty biopharmaceutical company commercializing and developing therapeutics and diagnostic tests. Its product Macimorelin, is an oral growth hormone secretagogue receptor agonist indicated for the diagnosis of Adult Growth Hormone Deficiency. The company was founded on September 12, 1990 and is headquartered in Charleston, SC.